Who bought Luminex?
DiaSorin
Italian diagnostics firm DiaSorin has concluded the acquisition of Luminex in an all-cash transaction for an equity value of nearly $1.8bn or $37 per share. In April, DiaSorin entered a definitive merger agreement to buy its US rival Luminex.
Is Luminex a good company to work for?
Is Luminex a good company to work for? Luminex has an overall rating of 3.4 out of 5, based on over 247 reviews left anonymously by employees. 59% of employees would recommend working at Luminex to a friend and 51% have a positive outlook for the business.
How many employees does Luminex Corporation have?
CEO & Founding Date. Luminex Corporation was founded in 1995 and its current CEO is Nachum Shamir. Since its inception 27 years ago, Luminex Corporation has grown to 1000 employees.
What happened to Luminex?
Per the deal, Luminex will get merged with DiaSorin’s newly formed U.S. subsidiary, with the former’s shareholders receiving $37 in cash for each of their shares. It is worth mentioning that the transaction will be funded through a mix of cash and external financing.
Where is DiaSorin based?
Saluggia, Italy
DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and since July 2021, it is also active in the Life Science business. The group was founded in 2000 and is headquartered in Saluggia, Italy.
Who founded Luminex?
Chandler co-founded the company with his brother, Van Chandler, in 1995. Mark Chandler has been chairman and CEO since then and has been president since June 1999. The company went public in March 2000; the initial public offering raised $76.5 million.
How many employees does DiaSorin have?
Diasorin Molecular LLC has 200 total employees across all of its locations and generates $90.00 million in sales (USD).
Is Luminex a public company?
Luminex Corporation | A DiaSorin Company is a biotechnology company which develops, manufactures and markets proprietary biological testing technologies with applications in life-sciences….Luminex Corporation.
| Type | Subsidiary |
|---|---|
| Industry | Biotechnology |
| Founded | 1995 |
| Headquarters | Austin, Texas, United States, |
What is Luminex made of?
Luminex beads (aka microspheres) make our technology one-of-a-kind. Microplex® microspheres are 5.6 µm in diameter and are made of polysterene. The small size allows for easy suspension in liquid, resulting in fast kinetics behavior.
How does a Luminex machine work?
Using a Luminex instrument, beads are excited by one laser to determine the bead region and corresponding assigned analyte. Another laser determines the magnitude of the PE-derived signal, which is proportional to the amount of analyte bound. Multiple readings are taken at each bead region, ensuring robust detection.
How much is Luminex worth?
$1.75 Billion
As of May 2022 Luminex has a market cap of $1.75 Billion.
How much does a Luminex cost?
Pricing for 10 or More Samples
| NUMBER OF MARKERS | 10-19 (per sample) | 20-38 (per sample) |
|---|---|---|
| 3 PLEX | $101.00 | $82.31 |
| 4 PLEX | $113.00 | $93.13 |
| 5 PLEX | $125.00 | $105.63 |
| 6 PLEX | $137.00 | $118.13 |
Is Luminex publicly traded?
Luminex trades on the NASDAQ under the ticker symbol “LMNX.”
How much does Luminex cost?
Pricing for 10 or More Samples
| NUMBER OF MARKERS | 10-19 (per sample) | 59-76 (per sample) |
|---|---|---|
| 2 PLEX | $89.00 | $56.00 |
| 3 PLEX | $101.00 | $61.08 |
| 4 PLEX | $113.00 | $66.95 |
| 5 PLEX | $125.00 | $73.73 |
Who is the CEO of Luminex?
53 employees have rated Luminex CEO Nachum “Homi” Shamir on Glassdoor.com. Nachum “Homi” Shamir has an approval rating of 87% among Luminex’s employees. Who are some of Luminex’s key competitors?
Are Luminex insiders buying or selling stock?
In the past three months, Luminex insiders have not sold or bought any company stock. Only 6.60% of the stock of Luminex is held by insiders. 87.76% of the stock of Luminex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Why Luminex for your lab?
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety.
Is Luminex’s dividend sustainable?
Luminex pays an annual dividend of $0.40 per share and currently has a dividend yield of 1.08%. Luminex does not yet have a strong track record of dividend growth. The dividend payout ratio of Luminex is 125.00%. Payout ratios above 75% are not desirable because they may not be sustainable.